Communication between skin and gastrointestinal tract in food allergy

食物过敏中皮肤和胃肠道之间的沟通

基本信息

项目摘要

 DESCRIPTION (provided by applicant): IgE-mediated food allergy affects approximately 5-8% of the US population, and there is no approved treatment. The current management strategy consists of allergen avoidance, but accidental ingestions are a common experience for patients. Severity of reactions is not predictable, and can range from mild hives to life- threatening systemic anaphylaxis. Sensitization commonly occurs in the first year of life, and the most predictive risk factor for food allergy is eczema. A developing paradigm is that exposure to foods via household dust promotes epicutaneous sensitization to foods in children with eczema, while dietary avoidance prevents the normal development of oral tolerance. Based on preliminary data, we hypothesize that inflammatory signals from the skin may also contribute to sensitization to foods encountered by the oral route. Using a model of tape-stripping that mimics the excoriations of atopic dermatitis, we observed that a single episode of mild skin damage leads to a significant change in the innate immune milieu of the small intestine. There is an induction of Th2 cytokine expression by resident innate and progenitor cells of the gastrointestinal tract, as well as an influx of innate cells into the inductive sites of the mucosa immune system. Furthermore, tape stripping in the absence of epicutaneous allergen exposure supports the generation of allergic symptoms when mice are repeatedly fed with the antigen. Based on our preliminary data, we hypothesize that signals generated from a compromised skin barrier act systemically to release progenitors from the bone marrow that home to the gastrointestinal tissues, and in addition drive an innate Th2 response from resident cells of the gastrointestinal tissues. This biased innate immune milieu thereby promotes IgE class switch in the mucosal tissues and impairs the development of oral tolerance. We will test this hypothesis in two specific aims. In the first aim, we will determine the mechanism by which damage to the skin leads to an altered immune milieu in the gastrointestinal tissues. We will examine the impact of mild tape stripping-induced injury on innate and progenitor cells in bone marrow, blood, skin, and gastrointestinal tract tissues, and study their cytokine expression using reporter mice. We will determine the role of skin cytokines in driving this innate immune response in the gastrointestinal tract. In the next aim we will determine the functional consequence of this altered immune milieu on the development of tolerance or sensitization to food antigens using mouse models of food allergy. Furthermore, we will examine the impact of the altered immune milieu on generation of Tfh cells and Tregs as well as class switch to IgE. Successful completion of our aims will provide us with a mechanistic understanding of the role of the skin in development of food allergy, and will help us to design appropriate strategies for the prevention of food allergy in early life.
 描述(由申请人提供):IgE介导的食物过敏影响约5-8%的美国人口,并且没有批准的治疗方法。目前的管理策略包括避免过敏原,但意外摄入是患者的常见经历。反应的严重程度是不可预测的,可以从轻微的荨麻疹到危及生命的全身过敏反应。致敏通常发生在生命的第一年,最具预测性的食物过敏风险因素是湿疹。一个发展中的范例是,通过家庭灰尘暴露于食物促进湿疹儿童对食物的表皮致敏,而避免饮食则会阻止口腔耐受性的正常发展。基于初步数据,我们假设来自皮肤的炎症信号也可能导致对经口途径接触的食物的致敏。使用模拟特应性皮炎表皮剥脱的胶带剥离模型,我们观察到轻度皮肤损伤的单次发作导致小肠先天免疫环境的显著变化。存在由胃肠道的固有和祖细胞诱导的Th 2细胞因子表达,以及固有细胞流入粘膜免疫系统的诱导位点。此外,在没有表皮过敏原暴露的情况下,胶带剥离支持当小鼠反复喂食抗原时过敏症状的产生。基于我们的初步数据,我们假设从受损的皮肤屏障产生的信号系统性地作用于从骨髓释放祖细胞,这些祖细胞归巢到胃肠道组织,并且另外驱动来自胃肠道组织的驻留细胞的先天性Th 2应答。因此,这种偏向性先天免疫环境促进粘膜组织中的IgE类别转换并损害口服耐受性的发展。我们将在两个具体目标中检验这一假设。在第一个目标中,我们将确定皮肤损伤导致胃肠道组织中免疫环境改变的机制。我们将研究轻度胶带剥离诱导的损伤对骨髓、血液、皮肤和胃肠道组织中先天性和祖细胞的影响,并使用报告基因研究它们的细胞因子表达。 小鼠我们将确定皮肤细胞因子在驱动胃肠道先天免疫反应中的作用。在下一个目标中,我们将使用食物过敏小鼠模型确定这种改变的免疫环境对食物抗原耐受性或致敏性发展的功能后果。此外,我们将研究改变的免疫环境对Tfh细胞和Tf 3产生的影响,以及IgE的类别转换。我们的目标的成功完成将为我们提供一个机械的理解的作用,皮肤在发展中的食物过敏,并将帮助我们设计适当的策略,预防食物过敏的早期生活。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Microbiome and food allergy.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria CECILIA BERIN其他文献

Maria CECILIA BERIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria CECILIA BERIN', 18)}}的其他基金

Immune Basis of FPIES
FPIES 的免疫基础
  • 批准号:
    10688156
  • 财政年份:
    2022
  • 资助金额:
    $ 21.19万
  • 项目类别:
Immune Basis of FPIES
FPIES 的免疫基础
  • 批准号:
    10502608
  • 财政年份:
    2022
  • 资助金额:
    $ 21.19万
  • 项目类别:
2022 Food Allergy Gordon Research Conference and Seminar
2022年食物过敏戈登研究会议暨研讨会
  • 批准号:
    10316398
  • 财政年份:
    2021
  • 资助金额:
    $ 21.19万
  • 项目类别:
Heterogeneity of T cell phenotype and function in food allergy
食物过敏中 T 细胞表型和功能的异质性
  • 批准号:
    10165496
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
Heterogeneity of T cell phenotype and function in food allergy
食物过敏中 T 细胞表型和功能的异质性
  • 批准号:
    10614529
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
Heterogeneity of T cell phenotype and function in food allergy
食物过敏中 T 细胞表型和功能的异质性
  • 批准号:
    10392434
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
Innate immunity in food allergy
食物过敏中的先天免疫
  • 批准号:
    9796540
  • 财政年份:
    2019
  • 资助金额:
    $ 21.19万
  • 项目类别:
Admin-Core
管理核心
  • 批准号:
    10415889
  • 财政年份:
    2018
  • 资助金额:
    $ 21.19万
  • 项目类别:
Immune Basis & Clinical implications of Threshold-Based Phenotypes of Peanut Allergy
免疫基础
  • 批准号:
    10415888
  • 财政年份:
    2018
  • 资助金额:
    $ 21.19万
  • 项目类别:
Immunologic basis of phenotypic heterogeneity in peanut allergy
花生过敏表型异质性的免疫学基础
  • 批准号:
    10415893
  • 财政年份:
    2018
  • 资助金额:
    $ 21.19万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了